0 CHECKOUT

Pancreatic Cancer - Pipeline Review, H1 2015

  • ID: 3345029
  • June 2015
  • 1617 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • 3B Pharmaceuticals GmbH
  • Astellas Pharma Inc.
  • CTI BioPharma Corp.
  • Ignyta, Inc.
  • Multimmune GmbH
  • Priaxon AG
  • MORE

Pancreatic Cancer - Pipeline Review, H1 2015

Summary

the, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Pancreatic Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pancreatic Cancer and special features on late-stage and discontinued projects.

the report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from the proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the team. Drug profiles/records featured in the report undergoes periodic updation following a stringent READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3B Pharmaceuticals GmbH
  • Astellas Pharma Inc.
  • CTI BioPharma Corp.
  • Ignyta, Inc.
  • Multimmune GmbH
  • Priaxon AG
  • MORE

Introduction
Pancreatic Cancer Overview
Therapeutics Development
Pancreatic Cancer – Therapeutics under Development by Companies
Pancreatic Cancer – Therapeutics under Investigation by Universities/Institutes
Pancreatic Cancer – Pipeline Products Glance
Pancreatic Cancer – Products under Development by Companies
Pancreatic Cancer – Products under Investigation by Universities/Institutes
Pancreatic Cancer – Companies Involved in Therapeutics Development
Pancreatic Cancer – Therapeutics Assessment
Drug Profiles
Pancreatic Cancer – Recent Pipeline Updates
Pancreatic Cancer – Dormant Projects
Pancreatic Cancer – Discontinued Products
Pancreatic Cancer – Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Pancreatic Cancer, H1 2015
Number of Products under Development for Pancreatic Cancer – Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Development by Companies, H1 2015 (Contd..7)
Number of Products under Development by Companies, H1 2015 (Contd..8)
Number of Products under Development by Companies, H1 2015 (Contd..9)
Number of Products under Development by Companies, H1 2015 (Contd..10)
Number of Products under Development by Companies, H1 2015 (Contd..11)
Number of Products under Development by Companies, H1 2015 (Contd..12)
Number of Products under Development by Companies, H1 2015 (Contd..13)
Number of Products under Development by Companies, H1 2015 (Contd..14)
Number of Products under Development by Companies, H1 2015 (Contd..15)
Number of Products under Development by Companies, H1 2015 (Contd..16)
Number of Products under Development by Companies, H1 2015 (Contd..17)
Number of Products under Development by Companies, H1 2015 (Contd..18)
Number of Products under Development by Companies, H1 2015 (Contd..19)
Number of Products under Development by Companies, H1 2015 (Contd..20)
Number of Products under Investigation by Universities/Institutes, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Development by Companies, H1 2015 (Contd..9)
Products under Development by Companies, H1 2015 (Contd..10)
Products under Development by Companies, H1 2015 (Contd..11)
Products under Development by Companies, H1 2015 (Contd..12)
Products under Development by Companies, H1 2015 (Contd..13)
Products under Development by Companies, H1 2015 (Contd..14)
Products under Development by Companies, H1 2015 (Contd..15)
Products under Development by Companies, H1 2015 (Contd..16)
Products under Development by Companies, H1 2015 (Contd..17)
Products under Development by Companies, H1 2015 (Contd..18)
Products under Development by Companies, H1 2015 (Contd..19)
Products under Development by Companies, H1 2015 (Contd..20)
Products under Development by Companies, H1 2015 (Contd..21)
Products under Development by Companies, H1 2015 (Contd..22)
Products under Development by Companies, H1 2015 (Contd..23)
Products under Development by Companies, H1 2015 (Contd..24)
Products under Development by Companies, H1 2015 (Contd..25)
Products under Development by Companies, H1 2015 (Contd..26)
Products under Development by Companies, H1 2015 (Contd..27)
Products under Development by Companies, H1 2015 (Contd..28)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..4)
Pancreatic Cancer – Pipeline by 3-V Biosciences, Inc., H1 2015
Pancreatic Cancer – Pipeline by 3B Pharmaceuticals GmbH, H1 2015
Pancreatic Cancer – Pipeline by 4SC AG, H1 2015
Pancreatic Cancer – Pipeline by AB Science, H1 2015
Pancreatic Cancer – Pipeline by AbbVie Inc., H1 2015
Pancreatic Cancer – Pipeline by AbGenomics International, Inc., H1 2015
Pancreatic Cancer – Pipeline by Ability Pharma, SL, H1 2015
Pancreatic Cancer – Pipeline by Adamed Sp. z o.o., H1 2015
Pancreatic Cancer – Pipeline by Adamis Pharmaceuticals Corporation, H1 2015
Pancreatic Cancer – Pipeline by Aduro BioTech, Inc., H1 2015
Pancreatic Cancer – Pipeline by Advantagene, Inc., H1 2015
Pancreatic Cancer – Pipeline by Advaxis, Inc., H1 2015
Pancreatic Cancer – Pipeline by AGV Discovery, SAS, H1 2015
Pancreatic Cancer – Pipeline by AIMM Therapeutics B.V., H1 2015
Pancreatic Cancer – Pipeline by Alchemia Limited, H1 2015
Pancreatic Cancer – Pipeline by Alethia Biotherapeutics Inc., H1 2015
Pancreatic Cancer – Pipeline by Allinky Biopharma, H1 2015
Pancreatic Cancer – Pipeline by Almac Discovery Limited, H1 2015
Pancreatic Cancer – Pipeline by Altor BioScience Corporation, H1 2015
Pancreatic Cancer – Pipeline by Ambrx, Inc., H1 2015
Pancreatic Cancer – Pipeline by Ambryx Biotechnology, Inc., H1 2015
Pancreatic Cancer – Pipeline by Amgen Inc., H1 2015
Pancreatic Cancer – Pipeline by Anavex Life Sciences Corp., H1 2015
Pancreatic Cancer – Pipeline by ANP Technologies, Inc., H1 2015
Pancreatic Cancer – Pipeline by APEIRON Biologics AG, H1 2015
Pancreatic Cancer – Pipeline by Apexigen, Inc., H1 2015
Pancreatic Cancer – Pipeline by Aphios Corporation, H1 2015
Pancreatic Cancer – Pipeline by APIM Therapeutics AS, H1 2015
Pancreatic Cancer – Pipeline by Apogenix GmbH, H1 2015
Pancreatic Cancer – Pipeline by Aposense Ltd., H1 2015
Pancreatic Cancer – Pipeline by Aptose Biosciences Inc., H1 2015
Pancreatic Cancer – Pipeline by Arch Biopartners, Inc., H1 2015
Pancreatic Cancer – Pipeline by Argon Pharma S.L., H1 2015
Pancreatic Cancer – Pipeline by Array BioPharma Inc., H1 2015
Pancreatic Cancer – Pipeline by Ascenta Therapeutics, Inc., H1 2015
Pancreatic Cancer – Pipeline by Astellas Pharma Inc., H1 2015
Pancreatic Cancer – Pipeline by AstraZeneca Plc, H1 2015
Pancreatic Cancer – Pipeline by Aurigene Discovery Technologies Limited, H1 2015
Pancreatic Cancer – Pipeline by AVEO Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by Axcentua Pharmaceuticals AB, H1 2015
Pancreatic Cancer – Pipeline by Azaya Therapeutics Incorporated, H1 2015
Pancreatic Cancer – Pipeline by Basilea Pharmaceutica AG, H1 2015
Pancreatic Cancer – Pipeline by Bavarian Nordic A/S, H1 2015
Pancreatic Cancer – Pipeline by Bayer AG, H1 2015
Pancreatic Cancer – Pipeline by Bellicum Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by BerGenBio AS, H1 2015
Pancreatic Cancer – Pipeline by Beta Pharma, Inc., H1 2015
Pancreatic Cancer – Pipeline by Bexion Pharmaceuticals, LLC., H1 2015
Pancreatic Cancer – Pipeline by BioCancell Ltd, H1 2015
Pancreatic Cancer – Pipeline by Biogenomics Limited, H1 2015
Pancreatic Cancer – Pipeline by Biomar Microbial Technologies, H1 2015
Pancreatic Cancer – Pipeline by BioMarin Pharmaceutical Inc., H1 2015
Pancreatic Cancer – Pipeline by Biomunex Pharmaceuticals, H1 2015
Pancreatic Cancer – Pipeline by Bioncotech Therapeutics S.L., H1 2015
Pancreatic Cancer – Pipeline by Bionomics Limited, H1 2015
Pancreatic Cancer – Pipeline by BiOrion Technologies B.V., H1 2015
Pancreatic Cancer – Pipeline by Biotest AG, H1 2015
Pancreatic Cancer – Pipeline by Biothera, Inc., H1 2015
Pancreatic Cancer – Pipeline by Biouniversa s.r.l., H1 2015
Pancreatic Cancer – Pipeline by Boehringer Ingelheim GmbH, H1 2015
Pancreatic Cancer – Pipeline by Boston Biomedical, Inc., H1 2015
Pancreatic Cancer – Pipeline by Bristol-Myers Squibb Company, H1 2015
Pancreatic Cancer – Pipeline by Calithera Biosciences, Inc., H1 2015
Pancreatic Cancer – Pipeline by Cantex Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by Cavion LLC, H1 2015
Pancreatic Cancer – Pipeline by Celgene Corporation, H1 2015
Pancreatic Cancer – Pipeline by Cellectis S.A., H1 2015
Pancreatic Cancer – Pipeline by Celsion Corporation, H1 2015
Pancreatic Cancer – Pipeline by Centrose Llc, H1 2015
Pancreatic Cancer – Pipeline by Ceronco Biosciences, H1 2015
Pancreatic Cancer – Pipeline by ChemoCentryx, Inc., H1 2015
Pancreatic Cancer – Pipeline by Chiome Bioscience, Inc., H1 2015
Pancreatic Cancer – Pipeline by Clovis Oncology, Inc., H1 2015
Pancreatic Cancer – Pipeline by Confluence Life Sciences, Inc., H1 2015
Pancreatic Cancer – Pipeline by Cornerstone Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by Critical Outcome Technologies Inc., H1 2015
Pancreatic Cancer – Pipeline by CritiTech, Inc., H1 2015
Pancreatic Cancer – Pipeline by CrystalGenomics, Inc., H1 2015
Pancreatic Cancer – Pipeline by CTI BioPharma Corp., H1 2015
Pancreatic Cancer – Pipeline by CureFAKtor Pharmaceuticals, LLC, H1 2015
Pancreatic Cancer – Pipeline by CureTech Ltd., H1 2015
Pancreatic Cancer – Pipeline by Cyclacel Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by CytomX Therapeutics, Inc., H1 2015
Pancreatic Cancer – Pipeline by CytoVac A/S, H1 2015
Pancreatic Cancer – Pipeline by CytRx Corporation, H1 2015
Pancreatic Cancer – Pipeline by CZ BioMed Corp, H1 2015
Pancreatic Cancer – Pipeline by Daewoong Pharmaceutical Co., Ltd., H1 2015
Pancreatic Cancer – Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Pancreatic Cancer – Pipeline by DEKK-TEC, Inc., H1 2015
Pancreatic Cancer – Pipeline by DiaMedica Inc., H1 2015
Pancreatic Cancer – Pipeline by Dicerna Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by e-Therapeutics Plc, H1 2015
Pancreatic Cancer – Pipeline by Eisai Co., Ltd., H1 2015
Pancreatic Cancer – Pipeline by Eleison Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by Eli Lilly and Company, H1 2015
Pancreatic Cancer – Pipeline by Erytech Pharma SA, H1 2015
Pancreatic Cancer – Pipeline by Esperance Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by Etubics Corporation, H1 2015
Pancreatic Cancer – Pipeline by Exelixis, Inc., H1 2015
Pancreatic Cancer – Pipeline by F. Hoffmann-La Roche Ltd., H1 2015
Pancreatic Cancer – Pipeline by FibroGen, Inc., H1 2015
Pancreatic Cancer – Pipeline by Fujifilm Corporation, H1 2015
Pancreatic Cancer – Pipeline by Fusion Antibodies Limited, H1 2015
Pancreatic Cancer – Pipeline by Ganymed Pharmaceuticals AG, H1 2015
Pancreatic Cancer – Pipeline by Genelux Corporation, H1 2015
Pancreatic Cancer – Pipeline by Genentech, Inc., H1 2015
Pancreatic Cancer – Pipeline by Genmab A/S, H1 2015
Pancreatic Cancer – Pipeline by Gilead Sciences, Inc., H1 2015
Pancreatic Cancer – Pipeline by GlaxoSmithKline Plc, H1 2015
Pancreatic Cancer – Pipeline by Globeimmune, Inc., H1 2015
Pancreatic Cancer – Pipeline by GlycoMimetics, Inc., H1 2015
Pancreatic Cancer – Pipeline by Golden Biotechnology Corp., H1 2015
Pancreatic Cancer – Pipeline by Halozyme Therapeutics, Inc., H1 2015
Pancreatic Cancer – Pipeline by Heat Biologics, Inc., H1 2015
Pancreatic Cancer – Pipeline by Helix BioPharma Corp., H1 2015
Pancreatic Cancer – Pipeline by Huabo Biopharm Co., Ltd., H1 2015
Pancreatic Cancer – Pipeline by Hutchison MediPharma Limited, H1 2015
Pancreatic Cancer – Pipeline by Igenica Biotherapeutics, Inc., H1 2015
Pancreatic Cancer – Pipeline by Ignyta, Inc., H1 2015
Pancreatic Cancer – Pipeline by Ildong Pharmaceutical Co., Ltd., H1 2015
Pancreatic Cancer – Pipeline by Immodulon Therapeutics Ltd., H1 2015
Pancreatic Cancer – Pipeline by Immune Pharmaceuticals Inc., H1 2015
Pancreatic Cancer – Pipeline by ImmunoCellular Therapeutics, Ltd., H1 2015
Pancreatic Cancer – Pipeline by Immunomedics, Inc., H1 2015
Pancreatic Cancer – Pipeline by Immunotope, Inc., H1 2015
Pancreatic Cancer – Pipeline by Immunovo BV, H1 2015
Pancreatic Cancer – Pipeline by Incuron, LLC, H1 2015
Pancreatic Cancer – Pipeline by Incyte Corporation, H1 2015
Pancreatic Cancer – Pipeline by Innopharmax Inc., H1 2015
Pancreatic Cancer – Pipeline by Inovio Pharmaceuticals, Inc., H1 2015
Pancreatic Cancer – Pipeline by Intezyne, Inc, H1 2015
Pancreatic Cancer – Pipeline by Intica Biomedical, Inc., H1 2015
Pancreatic Cancer – Pipeline by InvivoGen Therapeutics, H1 2015
Pancreatic Cancer – Pipeline by Io Therapeutics, Inc., H1 2015

List of Figures
Number of Products under Development for Pancreatic Cancer, H1 2015
Number of Products under Development for Pancreatic Cancer – Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

3-V Biosciences, Inc.
3B Pharmaceuticals GmbH
4SC AG
AB Science
AbbVie Inc.
AbGenomics International, Inc.
Ability Pharma, SL
Adamed Sp. z o.o.
Adamis Pharmaceuticals Corporation
Aduro BioTech, Inc.
Advantagene, Inc.
Advaxis, Inc.
AGV Discovery, SAS
AIMM Therapeutics B.V.
Alchemia Limited
Alethia Biotherapeutics Inc.
Allinky Biopharma
Almac Discovery Limited
Altor BioScience Corporation
Ambrx, Inc.
Ambryx Biotechnology, Inc.
Amgen Inc.
Anavex Life Sciences Corp.
ANP Technologies, Inc.
APEIRON Biologics AG
Apexigen, Inc.
Aphios Corporation
APIM Therapeutics AS
Apogenix GmbH
Aposense Ltd.
Aptose Biosciences Inc.
Arch Biopartners, Inc.
Argon Pharma S.L.
Array BioPharma Inc.
Ascenta Therapeutics, Inc.
Astellas Pharma Inc.
AstraZeneca Plc
Aurigene Discovery Technologies Limited
AVEO Pharmaceuticals, Inc.
Axcentua Pharmaceuticals AB
Azaya Therapeutics Incorporated
Basilea Pharmaceutica AG
Bavarian Nordic A/S
Bayer AG
Bellicum Pharmaceuticals, Inc.
BerGenBio AS
Beta Pharma, Inc.
Bexion Pharmaceuticals, LLC.
BioCancell Ltd
Biogenomics Limited
Biomar Microbial Technologies
BioMarin Pharmaceutical Inc.
Biomunex Pharmaceuticals
Bioncotech Therapeutics S.L.
Bionomics Limited
BiOrion Technologies B.V.
Biotest AG
Biothera, Inc.
Biouniversa s.r.l.
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Calithera Biosciences, Inc.
Cantex Pharmaceuticals, Inc.
Cavion LLC
Celgene Corporation
Cellectis S.A.
Celsion Corporation
Centrose Llc
Ceronco Biosciences
ChemoCentryx, Inc.
Chiome Bioscience, Inc.
Clovis Oncology, Inc.
Confluence Life Sciences, Inc.
Cornerstone Pharmaceuticals, Inc.
Critical Outcome Technologies Inc.
CritiTech, Inc.
CrystalGenomics, Inc.
CTI BioPharma Corp.
CureFAKtor Pharmaceuticals, LLC
CureTech Ltd.
Cyclacel Pharmaceuticals, Inc.
CytomX Therapeutics, Inc.
CytoVac A/S
CytRx Corporation
CZ BioMed Corp
Daewoong Pharmaceutical Co., Ltd.
Daiichi Sankyo Company, Limited
DEKK-TEC, Inc.
DiaMedica Inc.
Dicerna Pharmaceuticals, Inc.
e-Therapeutics Plc
Eisai Co., Ltd.
Eleison Pharmaceuticals, Inc.
Eli Lilly and Company
Erytech Pharma SA
Esperance Pharmaceuticals, Inc.
Etubics Corporation
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
FibroGen, Inc.
Fujifilm Corporation
Fusion Antibodies Limited
Ganymed Pharmaceuticals AG
Genelux Corporation
Genentech, Inc.
Genmab A/S
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Globeimmune, Inc.
GlycoMimetics, Inc.
Golden Biotechnology Corp.
Halozyme Therapeutics, Inc.
Heat Biologics, Inc.
Helix BioPharma Corp.
Huabo Biopharm Co., Ltd.
Hutchison MediPharma Limited
Igenica Biotherapeutics, Inc.
Ignyta, Inc.
Ildong Pharmaceutical Co., Ltd.
Immodulon Therapeutics Ltd.
Immune Pharmaceuticals Inc.
ImmunoCellular Therapeutics, Ltd.
Immunomedics, Inc.
Immunotope, Inc.
Immunovo BV
Incuron, LLC
Incyte Corporation
Innopharmax Inc.
Inovio Pharmaceuticals, Inc.
Intezyne, Inc
Intica Biomedical, Inc.
InvivoGen Therapeutics
Io Therapeutics, Inc.
Ipsen S.A.
Isarna Therapeutics GmbH
Jasco Pharmaceuticals, LLC.
Jiangsu Hengrui Medicine Co., Ltd.
Kadmon Corporation, LLC
KAEL-GemVax Co., Ltd.
Kalos Therapeutics, Inc.
Kancera AB
Karyopharm Therapeutics, Inc.
Keystone Nano, Inc.
LivTech, Inc.
Lymphocyte Activation Technologies, S.A.
MabVax Therapeutics Holdings, Inc.
Meabco A/S
Mebiopharm Co., Ltd.
MediaPharma s.r.l.
Medicon Pharmaceuticals, Inc
MedImmune, LLC
Medivation, Inc.
Medivir AB
Merck & Co., Inc.
Merck KGaA
Merrimack Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc.
Morphotek, Inc.
MSM Protein Technologies, Inc.
Multimmune GmbH
Nanobiotix
NanoCarrier Co., Ltd.
Nanotherapeutics, Inc.
Natco Pharma Limited
NatureWise Biotech & Medicals Corporation
NeoPharm Co., Ltd.
Nerviano Medical Sciences S.r.l.
NewLink Genetics Corporation
Northwest Biotherapeutics, Inc.
Novartis AG
NuCana BioMed Limited
Omeros Corporation
Omnitura Therapeutics Inc.
Oncodesign SA
Oncogenex Pharmaceuticals, Inc.
Oncology Research International Limited
Oncolytics Biotech Inc.
Oncomatrix, S.L.
OncoMed Pharmaceuticals, Inc.
Oncothyreon Inc.
Oncovir, Inc.
Ono Pharmaceutical Co., Ltd.
Optimum Therapeutics, LLC
Oscotec Inc.
Otsuka Holdings Co., Ltd.
Peregrine Pharmaceuticals, Inc.
Pfizer Inc.
Pharma Mar, S.A.
Pharma Two B Ltd
PharmAbcine, Inc.
Pharmacyclics, Inc.
PharmaCyte Biotech, Inc.
Pharmedartis GmbH
Philogen S.p.A.
Phoenix Biotechnology, Inc.
Pique Therapeutics
Plexxikon Inc.
Polaris Pharmaceuticals, Inc.
Precision Biologics, Inc.
Prescient Therapeutics Ltd
Priaxon AG
Prima BioMed Ltd.
ProMetic Life Sciences Inc.
Qu Biologics Inc.
Quest PharmaTech Inc.
Quimatryx, S.L.
RedHill Biopharma Ltd.
Rexahn Pharmaceuticals, Inc.
Rigontec GmbH
Samyang Holdings Corporation
Sanofi
Sareum Holdings Plc
Sentinel Oncology Limited
SignPath Pharma Inc
Silence Therapeutics Plc
Solasia Pharma K.K.
Sunesis Pharmaceuticals, Inc.
Symphogen A/S
Synovo GmbH
Synta Pharmaceuticals Corp.
Tactic Pharma, LLC
Taiho Pharmaceutical Co., Ltd.
Taiwan Liposome Company, Ltd.
Takara Bio Inc.
Takeda Pharmaceutical Company Limited
Targovax AS
TetraLogic Pharmaceuticals
Teva Pharmaceutical Industries Limited
Threshold Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc.
Transgene SA
TVAX Biomedical, Inc.
Tyg Oncology Ltd.
ValiRx Plc
VasGene Therapeutics, Inc.
Vaxeal Holding SA
Vaximm AG
Vaxon Biotech
VCN Biosciences SL
Vertex Pharmaceuticals Incorporated
Virobay Inc.
vTv Therapeutics Inc.
Welichem Biotech Inc.
Wilex AG
XOMA Corporation
XTuit Pharmaceuticals, Inc.
Zeria Pharmaceutical Co Ltd
Zhejiang BetaPharma Co., Ltd.
Zymeworks Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Novartis AG
  • Pfizer Inc.
  • Gilead Sciences Inc
  • Aduro Biotech Inc.
  • Celgene Corporation
  • Halozyme Inc.